This invention relates to catheter devices for performing transvascular cardiac procedures.
Recent developments in interventional cardiology have led to a need for creating a transvenous access pathway into an interventricular septum of a patient's heart. For example, this pathway could be used for novel catheter-based treatments for mitral valve regurgitation by a mitral loop cerclage, physiologic pacing, or septal reduction by intra-septal radiofrequency (RF) ablation for hypertrophic cardiomyopathy. This approach is relatively easier if the patient has a septal perforating vein into the interventricular septum. However, if the patient does not have a suitable septal perforating vein into the interventricular septum, this approach is more difficult. Thus, there is a need for a more general technique for creating a transvenous access pathway that could be used in patients with our without a suitable septal perforating vein.
This invention is for creating a transvenous access pathway into an interventricular septum of a patient's heart. There are a variety of different types of cardiac procedures for which such an access pathway could be useful, such as cardiac pacing, RF (radiofrequency) ablation, or mitral valve cerclage procedures. These are described in more detail below. The method uses a catheter device that is steerable at its distal end. An example of a catheter device that could be used include those described in patent application publication WO 2021/119636 (Tau Cardio, Inc.) titled “Septal Cross System”, which is incorporated by reference herein. Other examples of catheter devices that could be used are further described herein.
The catheter device comprises a main tube, which comprises a distal end segment, a distal tip, and a lumen. As used herein, ‘distal end segment’ means the portion of the main tube encompassing from the distal tip of the main tube to a distance of 5 cm inward (proximal) from the distal tip. The length of the main tube could be in the range of 60-180 cm long. The catheter device further comprises a puncture tool that travels through the lumen. The puncture tool could be inserted into the lumen of the catheter device at any suitable step in the cardiac procedure.
The main tube is inserted into an entry vein (such as the femoral, subclavian, or jugular vein). The main tube is advanced further into the vena cava (superior or inferior). The main tube is advanced into the right atrium of the heart. From there, the main tube is inserted into the coronary sinus and advanced through a coronary vein. Examples of coronary veins that could be traversed include tributaries that drain into the coronary sinus, such as the great cardiac vein, left ventricle vein, middle cardiac vein, left marginal vein, and septal perforating veins.
The distal tip is positioned at a target site within the coronary vein that is near the interventricular septum (e.g. within a distance of 4.0 cm). The puncture tool is introduced into the catheter device so that it travels through the main tube via a lumen of the main tube. The puncture tool could be any type of wire-like instrument that is capable of boring through the vein wall and into the myocardium. For example, the puncture tool could be a wire, drill tip, sharp needle point, etc.
The puncture tool is advanced through the lumen of the main tube in a distal direction along the path of the main tube (i.e. through the vena cava, right atrium, coronary sinus, and coronary vein). The puncture tool is advanced out of the distal tip opening of the main tube and is pushed to puncture through the vein wall. The puncture tool is further advanced into the myocardium towards the interventricular septum. This creates an entry passageway from the coronary vein, through the myocardium, and into the interventricular septum.
Any suitable amount of force may be used to puncture through the vein wall. In situations where the patient has a septal perforating vein and the distal tip of the main tube is positioned therein, relatively less force may be needed. For example, the amount of push force applied could be less than 0.20 N (newtons) to puncture through the vein wall. In other situations (e.g. where the patient does not have a septal perforating vein), relatively more push force may be needed. For example, the amount of push force applied could be in the range of 0.20-1.25 N (newtons) to puncture through the vein wall. This amount of force may be suitable in situations where the distal tip of the main tube is in the great cardiac vein, and puncture of the wall therethrough is required. For applying the pushing force, using the opposing wall of the coronary vein may be used as a buttress support at the distal end segment of the main tube.
In some embodiments, at the target site for puncturing the vein wall, the distal end segment of the main tube is bent at an angle relative to the longitudinal axis of the main tube. As such, the distal tip opening is pointed at an angle towards the vein wall. For example, this angle could be at least 45° relative to the longitudinal axis of the main tube. With this bend in the main tube, the puncture tool is advanced towards the vein wall at an angle and made to puncture therethrough.
In some embodiments, the main tube comprises a bendable segment at the distal end segment thereof. The bendable segment can be made to bend by operator control (e.g. like a steerable tip). In some cases, the bendable segment is more flexible than another segment of the main tube that is proximal to the bendable segment (e.g. the bendable segment is more flexible than other parts of the main tube). In some cases, the main tube comprises a coil element at the bendable segment thereof. Having a coil element makes the bendable segment have a spring-like compliance that improves the steering ability of the catheter device. In some cases, the length of the bendable segment is in the range of 10-40 mm long.
In some embodiments, the main tube comprises a pre-formed C-shape curve segment that extends from a proximal point A to a distal point B. Point A is located within an interval that is 6.0-15 cm of the distal tip of the main tube. Point B is located within an interval that is 0.4-4.0 cm from the distal tip of the main tube. Point B is located distal to point A. The length of the C-shape curve segment (distance from point A to point B) could be in the range of 5-20 cm long. In some cases, the steering wire is located on the inside curvature of the C-shape curve. In use, the main tube is inserted into the coronary sinus so that the C-shape curve of the main tube follows the curve of the coronary sinus. This pre-formed C-shape curve could help in setting the main tube at a good angle towards the coronary sinus and giving torque-ability through the coronary vein.
In some embodiments, the catheter device further comprises a steering wire that operates to cause bending of the main tube. The steering wire is fixed to the main tube at the distal end segment thereof. Bending is actuated by pushing or pulling the steering wire. Straightening or bending may be achieved by pushing or pulling, depending on the specific configuration of the catheter device. The distal end of the steering wire is affixed to the main tube near its distal tip. In some cases, the distal end of the steering wire is affixed to the main tube at a location on the main tube that is within 1.5 cm from the distal tip of the main tube. The length of the steering wire could be in the range of 80-200 cm long. The length of the steering wire may be shorter than the length of the puncture tool.
In some embodiments, the catheter device further comprises a handle assembly, which comprises a steering actuator. The steering wire is coupled to the steering actuator which acts to push or pull the steering wire. The steering actuator may have any suitable components to perform this action, such as knobs, dials, sliders, levers, etc.
In some embodiments, the main tube further comprises a second lumen that is separate from the (first) lumen. The steering wire travels through the separate second lumen of main tube. In some cases, the main tube comprises an exit hole out of the second lumen. The steering wire exits the second lumen out of the exit hole. This exit hole could be located at a point that is within 4-40 mm of the distal tip of the main tube.
In some embodiments, the distal end segment of the main tube comprises two or more radiopaque markers. The distance between the markers could be in the range of 2-8 mm. In some cases, the main tube comprises at least three radiopaque markers. This could be useful in allowing the operator to assess the amount of bending by imaging under x-ray fluoroscopy. The amount of deviation that the radiopaque markers are from straight alignment would indicate the degree of bending.
In some embodiments, the catheter device is used to perform a venogram of the heart. With the distal tip of the main tube inside the coronary sinus or further into a coronary vein, the contrast agent is injected through the catheter device and into the coronary vein. In some cases, a pressurized venogram is performed by putting a blockage at or near the (within 1.5 cm) of the coronary sinus entrance. This allows for a pressurized venogram to be performed to allow better visualization of smaller distal tributary veins of the coronary sinus.
In some embodiments, the method is used for a inserting an electrode lead into the patient's heart. Examples of electrode leads include those used for cardiac pacing or RF (radiofrequency) ablation. The method comprises introducing the electrode lead into the catheter device so that it travels the same path along the main tube, and then through the entry passageway in the myocardium, and into the interventricular septum. The electrode of the electrode lead is positioned inside the interventricular septum. In situations where the same lumen is used for advancing the electrode lead, the puncture tool is withdrawn out of the catheter device, and the electrode lead is advanced through this same lumen of the main tube.
Cardiac pacing in the interventricular septum may be useful for treating dysrhythmias. For example, the treatment could be para-Hisian pacing of the right ventricular close to the His bundle or proximal right bundle branch (RBB). This may be useful in patients who have atrioventricular (AV) block as a cause of their dysrhythmia. RF (radiofrequency) ablation in the interventricular septum may be useful for treating various cardiac disease conditions, such as hypertrophic cardiomyopathy.
In some embodiments, the method is used for a mitral valve cerclage procedure. Examples of such procedures are described in Kim et al, “Mitral cerclage annuloplasty, a novel transcatheter treatment for secondary mitral valve regurgitation: Initial results in swine” (2009) J Am Coll Cardiol. 54(7): 638-651; and Park et al, “Mitral Loop Cerclage Annuloplasty for Secondary Mitral Regurgitation: First Human Results” (2017) JACC Cardiovasc Interv. 10(6): 597-610. These references are incorporated by reference herein.
The method comprises introducing the mitral loop cerclage wire into the catheter device so that it travels the same path along the main tube, and then through the entry passageway in the myocardium, and into the interventricular septum. The mitral loop cerclage wire may then exit out of the interventricular septum to form the desired loop. In situations where the same lumen is used for advancing the cerclage wire, the puncture tool is withdrawn out of the catheter device, and the cerclage wire is advanced through this same lumen of the main tube.
To assist in understanding the invention, reference is made to the accompanying drawings to show by way of illustration specific embodiments in which the invention may be practiced. The drawings herein are not necessarily made to scale or actual proportions. For example, lengths and widths of the components may be adjusted to accommodate the page size.
Towards the proximal end 13, the catheter device 10 comprises a handle assembly 50, which comprises a cone-shaped hood 88 where the main tube 20 attaches thereto. The handle assembly 50 further comprises a handle grip 86. At the back of the handle assembly 50, there is a hub 56 with a main port 84 and an accessory port 82. A guidewire and puncture tool (not shown here) is inserted into main port 84, which is the opening for the primary lumen 26 (not shown here) of the main tube 20. The handle assembly 50 comprises a twist knob 52 and a slider 54. There is a spiral railing 80 on the inside of twist knob 52. The twist knob 52 engages with the slider 54 on the spiral railing 80. With this configuration, turning the twist knob 52 (clockwise or counterclockwise) causes the slider 54 to move forward or backwards as driven by the spiral railing 80. As explained in more detail below, this causes bending at the bendable segment 34 of the main tube 20.
The steering wire 40 exits the secondary lumen 28 out through the proximal side hole 24 and travels alongside and external to the body of the main tube 20. The steering wire 40 reenters the main body 20 through distal side hole 22. Within the main tube 20, the distal end of steering wire 40 is embedded therein. In this way, the distal end of steering wire 40 is attached to near the distal tip 20a of the main tube 20. A distal hole 22 is not necessary for attachment of the steering wire 40 to the main tube 20. For example, in other embodiments, the distal end of the steering wire 40 could be attached to the outer surface of the main tube 20 at or near its distal tip 20a.
The main tube 20 also has a pre-formed C-shape curve segment 88. That is, the main tube 20 at this curve segment 88 has a bias to form C-shape. This curve segment 88 encompasses a portion of the main tube 20 from the proximal end of the bendable segment 34 to a point further proximal thereof. In this example, the C-shape curve segment 88 has a length L4 of about 10 cm. This C-shape curve is compatible with the natural curving path of the coronary sinus. Having this C-shape curve may be useful in ensuring that the main shaft 20 is oriented so that bending at the bendable segment 34 correctly points the distal tip inward towards the interventricular septum when the vein puncture is performed.
The main tube 20 has three radiopaque marker bands 32 that are 1.0 mm wide for imaging under x-ray fluoroscopy. This allows the operator to assess the position of the distal end portion of the main tube 20. Here, the marker bands 32 are spaced at a distance of about 5 mm apart. Having multiple marker bands 32 in spaced intervals allows the operator to also assess the shape of the distal end portion of the main tube 20, i.e. amount of bending thereof. For example, a straight alignment of the three marker bands 32 would indicate no bending at the distal end portion of the main tube 20. However, the three marker bands 32 being out of straight alignment would give the operator an estimate of the amount of bending.
In
In
In
In
In
In this approach to the interventricular septum 64, the main tube 20 may travel through other coronary veins such as a septal perforator vein. However, not all people have a septal perforator vein, and this invention does not require the presence of such. With the catheter device 10 in position at the target site, the guidewire is then exchanged with the puncture tool 44. The bendable portion 34 of the main tube 20 is made to bend. The puncture tool 44 is advanced forward so that it punctures through the cardiac vein 66 at an angle and penetrates into the myocardium towards the interventricular septum 64.
The puncture tool 44 creates an entry passageway into the myocardium to the interventricular septum 64. With this entry passageway established, the puncture tool 44 is exchanged for the electrode lead or cerclage wire (not shown here). In the case of an electrode lead, it is advanced so that its electrode is positioned inside the interventricular septum 64. The electrode lead is thus implanted in the interventricular septum 64 and can be activated (e.g. for cardiac pacing or ablation treatment).
Prototypes of the experimental catheter device were tested in 10 swine animals. The procedure was performed by inserting a sheath into the entry vein (jugular, subclavian, or femoral vein). A first guidewire was inserted through this sheath and maneuvered into the coronary sinus. Along this guidewire path, a balloon-tipped guiding catheter was introduced into the heart and into the coronary sinus. The balloon was engaged with the coronary sinus to form a seal and radiopaque contrast agent was injected under pressure to obtain an x-ray fluoroscopic image (i.e. pressurized venogram). This pressurized venogram confirmed whether or not a septal perforator vein was present in the subject swing animal.
The first guidewire was exchanged with a thinner second guidewire for introducing the experimental catheter device. This thinner guidewire was advanced into the great cardiac vein. The catheter device was introduced along this guidewire into the great cardiac vein and positioned at a suitable place and vector direction to engage the septal myocardium. At this point, the distal end of the catheter device was bent at an angle towards the septal myocardium
The second guidewire was exchanged with a stiffer third guidewire to serve as a puncture wire. The puncture wire was pushed forward to puncture directly through the wall of the great cardiac vein and enter the myocardium towards the septum. The amount of force needed to push the puncture wire through the vein wall and into the myocardium was measured using a push-pull gauge. A force of 0.45 N (newtons) was required to penetrate through the vein wall. Once inside the myocardium, a lesser force of 0.04 N was needed to push through the myocardium tissue.
With guidance by x-ray fluoroscopy, the puncture wire was further advanced to the target site within the interventricular septum. Ultrasound echocardiography and x-ray fluoroscopy confirmed that the puncture wire was in the desired location. This puncture procedure was successfully performed in all 10 of the swine animals.
After the procedure experiments were completed, the hearts were harvested for visual pathologic and histopathologic examination. On visual examination, there was no significant systematic damage to the blood vessels or myocardial walls. There was a hematoma around the puncture site, but there was no spread of the hematoma or severe damage to other areas. There was no hemorrhage in the epicardium where the guidewire entered the myocardium. With microscopic histopathology examination, no myocardial damage was seen. There were some hemorrhagic foci in the myocardium and epicardium. But there was no ischemic damage or necrosis.
The descriptions and examples given herein are intended merely to illustrate the invention and are not intended to be limiting. Each of the disclosed aspects and embodiments of the invention may be considered individually or in combination with other aspects, embodiments, and variations of the invention. In addition, unless otherwise specified, the steps of the methods of the invention are not confined to any particular order of performance. Modifications of the disclosed embodiments incorporating the spirit and substance of the invention may occur to persons skilled in the art, and such modifications are within the scope of the invention.
Any use of the word “or” herein is intended to be inclusive and is equivalent to the expression “and/or,” unless the context clearly dictates otherwise. As such, for example, the expression “A or B” means A, or B, or both A and B. Similarly, for example, the expression “A, B, or C” means A, or B, or C, or any combination thereof.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US22/33320 | 6/13/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63209962 | Jun 2021 | US | |
63221813 | Jul 2021 | US |